BNR · Burning Rock Biotech Ltd · Metrics
$13.32
+0.25 (+1.91%)
At close · Nov 19
Return incl. dividend (before tax)
Q1 2024 earnings call transcript
Market Cap
$140.48M
Shares
10.55M
Volume · Nov 19
29.47K
Avg daily vol (3M)
35.68K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
BNR metrics
66 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$13.32
Market cap
$140.48M
Price action
23 metricsPrice change (1W)
-0.1%
Price change (30D)
-1.4%
Price change (3M)
+44.0%
Price change (6M)
-18.4%
Price change (YTD)
-33.9%
Price change (1Y)
-16.9%
Trailing year
Price change (5Y)
—
52-week high
$41.06
52-week low
$7.04
Change from 52-week high
-67.6%
Change from 52-week low
+89.2%
Annualized volatility
124.0%
Annualized volatility (3M)
114.4%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.9
RSI (14D)
52.5
Price vs SMA 50
-4.0%
Price vs SMA 200
-11.0%
Avg volume (3M)
35,675
Relative volume
0.8
Average dollar volume
$471,479
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
10.55M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.1×
reciprocal yield 90.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.0×
reciprocal yield 51.0%
P / book
1.9
reciprocal yield 52.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2024-03-29
Profitability
9 metricsGross margin
74.6%
Operating margin
-13.0%
Trailing 12 months
Net margin
-13.6%
Gross profit (TTM)
$373.23M
Operating profit (TTM)
−$65.02M
Net income (TTM)
−$9.74M
Trailing 12 months
Diluted EPS (TTM)
$-0.93
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-9.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$71.61M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-100.0%
Year over year · fewer shares
Revenue CAGR (3Y)
-1.4%
Revenue CAGR (5Y)
+4.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-13.7%
Return on assets
-9.1%
Debt / equity
0.0
Current ratio
3.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$61.17M
Latest balance sheet
Cash & equivalents
$61.43M
Total assets
$110.63M
Total debt
$265,287
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$1.75M
Capital expenditures (TTM)
—
R&D (TTM)
−$19.28M
SG&A (TTM)
−$43.40M
Stock compensation (TTM)
—
R&D / revenue
-27.0%
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
17
13F filer change QoQ
0
Institutional ownership
16.1%
Conviction holders (share of 13F filers)
5.9%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.1%
Holder tenure
18.0
Price vs estimated holder cost
+25.2%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.1%
Short interest
3 metricsShort interest
0.3%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
40 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1792267
CUSIP
12233L206
13F (30d)
19 filings
17 filers
Visit website
Investor relations